Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults

Genes Chromosomes and Cancer

Volumn 47, Issue 7, 2008, Pages 547-557

  McIntyre, Alan ^a   Gilbert, Duncan ^a   Goddard, Neil ^a   Looijenga, Leendart ^b   Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; K RAS PROTEIN; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAF PROTEIN; STAT PROTEIN; STEM CELL FACTOR;

ADULTHOOD; CELL DIFFERENTIATION; CELL STRUCTURE; CHROMOSOME; CHROMOSOME 12; CLINICAL FEATURE; EMBRYONAL TISSUE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SEMINOMA; SIGNAL TRANSDUCTION; STEM CELL;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN; GENES; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS;

EID: 44349138163     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20562     Document Type: Review

References (129)

1. Aguirre D, Nieto K, Lazos M, Pena YR, Palma I, Kofman-Alfaro S, Queipo G. 2006. Extragonadal germ cell tumors are often associated with Klinefelter syndrome. Hum Pathol 37:477-480.
2. Aigner A, Brachmann P, Beyer J, Jager R, Raulais D, Vigny M, Neubauer A, Heidenreich A, Weinknecht S, Czubayko F, Zugmaier G. 2003. Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14:1525-1529.
3. Albanell J, Bosl GJ, Reuter VE, Engelhardt M, Franco S, Moore MA, Dmitrovsky E. 1999. Telomerase activity in germ cell cancers and mature teratomas. J Natl Cancer Inst 91:1321-1326.
4. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. 2004. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64:4736-4743.
5. Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U, Ansorge W, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. 2005. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumors. Br J Cancer 92:1934-1941.
6. Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P, Draper JS. 2005. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: Opposite sides of the same coin. Biochem Soc Trans 33:1526-1530.
7. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J, Stojkovic M, Lako M. 2006. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15:1894-1913.
8. Baldassarre G, Romano A, Armenante F, Rambaldi M, Paoletti I, Sandomenico C, Pepe S, Staibano S, Salvatore G, De Rosa G, Persico MG, Viglietto G. 1997. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 15:927-936.
9. Bonner MR, McCann SE, Moysich KB. 2002. Dietary factors and the risk of testicular cancer. Nutr Cancer 44:35-43.
10. Campbell PM, Der CJ. 2004. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14:105-114.
11. Chaganti RS, Houldsworth J. 2000. Genetics and biology of adult human male germ cell tumors. Cancer Res 60:1475-1482.
12. Chew G, Hutson JM. 2004. Incidence of cryptorchidism and ascending testes in trisomy 21: A 10 year retrospective review. Pediatr Surg Int 20:744-747.
13. Cox AD, Der CJ. 2003. The dark side of Ras: Regulation of apoptosis. Oncogene 22:8999-9006.
14. De Felici M. 2000. Regulation of primordial germ cell development in the mouse. Int J Dev Biol 44:575-580.
15. de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, Looijenga LH. 2008. Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 47:185-196.
16. De Miguel MP, Cheng L, Holland EC, Federspiel MJ, Donovan PJ. 2002. Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer. Proc Natl Acad Sci USA 99:10458-10463.
17. Di Vizio D, Cito L, Boccia A, Chieffi P, Insabato L, Pettinato G, Motti ML, Schepis F, D'Amico W, Fabiani F, Tavernise B, Venuta S, Fusco A, Viglietto G. 2005. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24:1882-1894.
18. Dieckmann KP, Endsin G, Pichlmeier U. 2001. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 40:677-683; discussion 684.
19. Dieckmann KP, Pichlmeier U. 2002. Is risk of testicular cancer related to body size? Eur Urol 42:564-569.
20. Diez-Torre A, Silvan U, De Wever O, Bruyneel F, Marcel M, Arechaga J. 2004. Germinal tumor invasion and the role of the testicular stroma. Int J Dev Biol 48:545-557.
21. Downward J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11-22.
22. Downward J. 2004. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15:177-182.
23. Ekbom A, Richiardi L, Akre O, Montgomery SM, Sparen P. 2003. Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95:1238-1240.
24. English PB, Goldberg DE, Wolff C, Smith D. 2003. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 14:815-825.
25. Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LH, Friedlander ML. 2000. Allelic losses in carcinoma in situ and testicular germ cell tumors of adolescents and adults: Evidence suggestive of the linear progression model. Br J Cancer 83:729-736.
26. Felici MD, Carlo AD, Pesce M, Iona S, Farrace MG, Piacentini M. 1999. Bcl-2 and Bax regulation of apoptosis in germ cells during prenatal oogenesis in the mouse embryo. Cell Death Differ 6:908-915.
27. Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, Chilvers CE, Pike MC. 1992. Familial testicular cancer: A report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 65:255-262.
28. Fukuda S, Shirahama T, Imazono Y, Tsushima T, Ohmori H, Kayajima T, Take S, Nishiyama K, Yonezawa S, Akiba S, Akiyama S, Ohi Y. 1999. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer 85:1323-1330.
29. Garcia-Rodriguez J, Garcia-Martin M, Nogueras-Ocana M, de Dios Luna-del-Castillo J, Espigares Garcia M, Olea N, Lardelli-Claret P. 1996. Exposure to pesticides and cryptorchidism: Geographical evidence of a possible association. Environ Health Perspect 104:1090-1095.
30. Garner MJ, Birkett NJ, Johnson KC, Shatenstein B, Ghadirian P, Krewski D. 2003. Dietary risk factors for testicular carcinoma. Int J Cancer 106:934-941.
31. Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, van der Spek PJ, de Alarcon P, Looijenga LH. 2007. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213:319-328.
32. Giuliano CJ, Kerley-Hamilton JS, Bee T, Freemantle SJ, Manickaratnam R, Dmitrovsky E, Spinella MJ. 2005. Retinole acid represses a cassette of candidate pluripoteney chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta 1731:48-56.
33. Giwercman A, Muller J, Skakkeboek NE. 1988. Cryptorchidism and testicular neoplasia. Horm Res 30:157-163.
34. Goddard NC, McIntyre A, Summersgill B, Gilbert D, Kitazawa S, Shipley J. 2007. KIT and RAS signalling pathways in testicular germ cell tumours: New data and a review of the literature. Int J Androl 30:337-348; discussion 349.
35. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, Nolte J, Wolf F, Li M, Engel W, Hasenfuss G. 2006. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440:1199-1203.
36. Guo JH, Zhu PY, Huang YF, Yu L. 2002. Autosomal aberrations associated with testicular dysgenesis or spermatogenic arrest in Chinese patients. Asian J Androl 4:3-7.
37. Han DC, Shen TL, Guan JL. 2001. The Grb7 family proteins: Structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321.
38. Hasle H, Mellemgaard A, Nielsen J, Hansen J. 1995. Cancer incidence in men with Klinefelter syndrome. Br J Cancer 71:416-420.
39. Hirai K, Sasaki H, Yamamoto H, Sakamoto H, Kubota Y, Kakizoe T, Terada M, Ochiya T. 2004. HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition. Exp Cell Res 294:77-85.
40. Honecker F, Stoop H, de Krijger RR, Chris Lau YE, Bokemeyer C, Looijenga LH. 2004. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 203:849-857.
41. Hong L, Munugalavadla V, Kapur R. 2004. c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways. Mol Cell Biol 24:1401-1410.
42. Horwich A, Dearnaley DP, Nicholls J, Jay G, Mason M, Harland S, Peckham MJ, Hendry WF. 1991. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol 9:62-69.
43. Houbaviy HB, Murray MF, Sharp PA. 2003. Embryonic stem cell-specific MicroRNAs. Dev Cell 5:351-358.
44. Houldsworth J, Reuter V, Bosl GJ, Chaganti RS. 1997. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 8:293-299.
45. Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, Bosl GJ, Chaganti RS. 1998. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 16:2345-2349.
46. Hsieh CC, Lambe M, Trichopoulos D, Ekbom A, Akre O, Adami HO. 2002. Early life exposure to oestrogen and testicular cancer risk: Evidence against an aetiological hypothesis. Br J Cancer 86:1363-1364.
47. Izquierdo MA, Van der Valk P, Van Ark-Otte J, Rubio G, Germa-Lluch JR, Ueda R, Scheper RJ, Takahashi T, Giaccone G. 1995. Differential expression of the c-kit proto-oncogene in germ cell tumors. J Pathol 177:253-258.
48. Jacobsen GK, Henriques UV. 1992. A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol 5:547-549.
49. Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, Moller H. 2000. Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. Bmj 321:789-792.
50. Juric D, Sale S, Hromas RA, Yu R, Wang Y, Duran GE, Tibshirani R, Einhorn LH, Sikic BI. 2005. Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci USA 102:17763-17768.
51. Kaijser M, Akre O, Cnattingius S, Ekbom A. 2003. Maternal lung cancer and testicular cancer risk in the offspring. Cancer Epidemiol Biomark Prev 12:643-646.
52. Kamai T, Arai K, Sumi S, Tsujii T, Honda M, Yamanishi T, Yoshida KI. 2002. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumor. BJU Int 89:449-453.
53. Kawakami T, Zhang C, Okada Y, Okamoto K. 2006. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin. Oncogene 25:3225-3236.
54. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC. 2004. KIT mutations are common in testicular seminomas. Am J Pathol 164:305-313.
55. Kierszenbaum AL, Tres LL. 2001. Primordial germ cell-somatic cell partnership: A balancing cell signaling act. Mol Reprod Dev 60:277-280.
56. Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, Ikeuchi M, Nagy A, Mak TW, Nakano T. 2003. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130:1691-1700.
57. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. 2004. Klinefelter's syndrome. Lancet 364:273-283.
58. Lassurguere J, Livera G, Habert R, Jegou B. 2003. Time- And dose-related effects of estradiol and diethylstilbestrol on the morphology and function of the fetal rat testis in culture. Toxicol Sci 73:160-169.
59. Leaman DW, Leung S, Li X, Stark GR. 1996. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588.
60. Li J, Xia F, Li WX. 2003. Coactivation of STAT and Ras is required for germ cell proliferation and invasive migration in Drosophila. Dev Cell 5:787-798.
61. Linke J, Loy V, Dieckmann KP. 2005. Prevalence of testicular intraepithelial neoplasia in healthy males. J Urol 173:1577-1579.
62. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, FossÅ SD, Oosterhuis JW. 2003. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 63:7674-7678.
63. Looijenga LH, Rosenberg C, van Gurp RJ, Geelen E, van Echten-Arends J, de Jong B, Mostert M, Wolter Oosterhuis J. 2000. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol 191:187-192.
64. Looijenga LH, Gillis AJ, Stoop H, Hersmus R, Oosterhuis JW. 2007. Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumors. Int J Androl 30:304-314
65. Mandoky L, Geczi L, Bodrogi I, Toth J, Csuka O, Kasler M, Bak M. 2004. Clinical relevance of HER-2/neu expression in germ-cell testicular tumors. Anticancer Res 24:2219-2224.
66. Marte BM, Downward J. 1997. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355-358.
67. Mavilio F, Simeone A, Boncinelli E, Andrews PW. 1988. Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 37:73-79.
68. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RF. 2003. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63-70.
69. McIntyre A, Summersgill B, Grygalewicz B, Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R, Cooper C, Clark J, Oosterhuis JW, Looijenga LH, Shipley J. 2005a. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65:8085-8089.
70. McIntyre A, Summersgill B, Jafer O, Rodriguez S, Zafarana G, Oosterhuis JW, Gillis AJ, Looijenga L, Cooper C, Huddart R, Clark J, Shipley J. 2004. Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analvsis of cDNA clones. Oncogene 23:9142-9147.
71. McIntyre A, Summersgill B, Spendlove HE, Huddart R, Houlston R, Shipley J. 2005b. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 7:1047-1052.
72. McIntyre A, Summersgill B, Lu YJ, Missiaglia E, Kitazawa S, Oosterhuis JW, Looijenga LH, Shipley J. 2007. Genomic copy number and expression patterns in testicular germ cell tumours. Br J Cancer 97:1707-1712.
73. Meyts ER, Jorgensen N, Muller J, Skakkebaek NE. 1996. Prolonged expression of the c-kit receptor in germ cells of intersex fetal testes. J Pathol 178:166-169.
74. Miyagi C, Yamashita S, Ohba Y, Yoshizaki H, Matsuda M, Hirano T. 2004. STAT3 noncell-autonomously controls planar cell polarity during zebrafish convergence and extension. J Cell Biol 166:975-981.
75. Moe-Behrens GH, Klinger FG, Eskild W, Grotmol T, Haugen TB, De Felici M. 2003. Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 17:2630-2638.
76. Montgomery SM, Granath F, Ehlin A, Sparen P, Ekbom A. 2005. Germ-cell testicular cancer in offspring of Finnish immigrants to Sweden. Cancer Epidemiol Biomark Prev 14:280-282.
77. Moroni M, Veronese S, Schiavo R, Carminati O, Sorensen BS, Gambacorta M, Siena S. 2001. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors. Clin Cancer Res 7:2770-2775.
78. Mosselman S, Looijenga LH, Gillis AJ, van Rooijen MA, Kraft HJ, van Zoelen EJ, Oosterhuis JW. 1996. Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci USA 93:2884-2888.
79. Mostofi FK. 1973. Proceedings: Testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer 32:1186-1201.
80. Moul JW, Schanne FJ, Thompson IM, Frazier HA, Peretsman SA, Wettlaufer JN, Rozanski TA, Stack RS, Kreder KJ, Hoffman KJ. 1994. Testicular cancer in blacks. A multicenter experience. Cancer 73:388-393.
81. Murty VV, Chaganti RS. 1998. A genetic perspective of male germ cell tumors. Semin Oncol 25:133-144.
82. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. 2005. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123:917-929.
83. Olie RA, Looijenga LH, Boerrigter L, Top B, Rodenhuis S, Langeveld A, Mulder MP, Oosterhuis JW. 1995. N- and KRAS mutations in primary testicular germ cell tumors: Incidence and possible biological implications. Genes Chromosomes Cancer 12:110-116.
84. Oliver RT 1987. HLA phenotype and clinicopathological behaviour of germ cell tumors: Possible evidence for clonal evolution from seminomas to nonseminomas. Int J Androl 10:85-93.
85. Ondrus D, Kuba D, Chrenova S, Matoska J. 1997. Familial testicular cancer and developmental anomalies. Neoplasma 44:59-61.
86. Oosterhuis JW, Castedo SM, de Jong B, Cornelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H. 1989. Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest 60:14-21.
87. Oosterhuis JW, Looijenga LH. 2005. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 5:210-222.
88. Ottesen AM, Skakkebaek NE, Lundsteen C, Leffers H, Larsen J, Rajpert-De Meyts E. 2003. High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development. Genes Chromosomes Cancer 38:117-125.
89. Parkin DM, Iscovich J. 1997. Risk of cancer in migrants and their descendants in Israel. II. Carcinomas and germ-cell tumors. Int J Cancer 70:654-660.
90. Pero SC, Oligino L, Daly RJ, Soden AL, Liu C, Roller PP, Li P, Krag DN. 2002. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem 277:11918-11926.
91. Pero SC, Shukla GS, Armstrong AL, Peterson D, Fuller SP, Godin K, Kingsley-Richards SL, Weaver DL, Bond J, Krag DN. 2004. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells. Int J Cancer 111:951-960.
92. Pettersson A, Kaijser M, Richiardi L, Askling J, Ekbom A, Akre O. 2004. Women smoking and testicular cancer: One epidemic causing another? Int J Cancer 109:941-944.
93. Rapley EA, Crockford GP, Easton DF, Stratton MR, Bishop DT 2003. Localisation of susceptibility genes for familial testicular germ cell tumor. Apmis 111:128-133; discussion 33-35.
94. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossa SD, Tucker K, Donald J, Collins F, Friedlander M, Hogg D, Goss P, Heidenreich A, Ormiston W, Daly PA, Forman D, Oliver TD, Leahy M, Huddart R, Cooper CS, Bodmer JG, Easton DF, Stratton MR, Bishop DT. 2000. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumors. Nat Genet 24:197-200.
95. Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Einhorn L, Weber BL, McMaster M, Greene MH, Bishop DT, Easton D, Stratton MR. 2004. Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 90:2397-2401.
96. Richiardi L, Akre O, Lambe M, Granath F, Montgomery SM, Ekbom A. 2004a. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 15:323-329.
97. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyezynski JE, Akre O. 2004b. Testicular cancer incidence in eight northern European countries: Secular and recent trends. Cancer Epidemiol Biomark Prev 13:2157-2166.
98. Roelofs H, Mostert MC, Pompe K, Zafarana G, van Oorschot M, van Gurp RJ, Gillis AJ, Stoop H, Beverloo B, Oosterhuis JW, Bokemeyer C, Looijenga LH. 2000. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol 157:1155-1166.
99. Ronnstrand L. 2004. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 61:2535-2548.
100. Rosenberg C, Van Gurp RJ, Geelen E, Oosterhuis JW, Looijenga LH. 2000. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 19:5858-5862.
101. Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Symmans WF, Pusztai L, Hortobagyi GN. 2004. Targeted therapy in breast cancer: The HER-2/neu gene and protein. Mol Cell Proteomics 3:379-398.
102. Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ. 1997. An excess of testicular germ cell tumors in Down's syndrome: Three case reports and a review of the literature. Cancer 80:929-935.
103. Sharpe RM. 2003. The 'oestrogen hypothesis'- where do we stand now? Int J Androl 26:2-15.
104. Skakkebaek NE. 1972. Possible carcinoma-in-situ of the testis. Lancet 2:516-517.
105. Skakkebaek NE. 2002. Endocrine disrupters and testicular dysgenesis syndrome. Horm Res 57Suppl 2:43.
106. Skakkebaek NE. 2003. Testicular dysgenesis syndrome. Horm Res 60Suppl 3:49.
107. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N, Rajpert-De Meyts E. 2003. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis. Apmis 111:1-9; discussion 9-11.
108. Skakkebaek NE, Rajpert-De Meyts E, Main KM. 2001. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972-978.
109. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA. 2005. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65:5588-5598.
110. Sommerer F, Hengge UR, Markwarth A, Vomschloss S, Stolzenburg JU, Wittekind C, Tannapfel A. 2005. Mutations of BRAF and RAS are rare events in germ cell tumors. Int J Cancer 113:329-335.
111. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA. 2003. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 100:13350-13355.
112. Stalloek J, Molyneaux K, Schaible K, Knudson CM, Wylie C. 2003. The pro-apoptotic gene Bax is required for the death of ectopic primordial germ cells during their migration in the mouse embryo. Development 130:6589-6597.
113. Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ. 1991. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51:1811-1816.
114. Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, Kaufman RH, Adam E, Herbst AL, Hatch EE. 2001. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 93:545-551.
115. Summersgill B, Osin P, Lu YJ, Huddart R, Shipley J. 2001. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 85:213-220.
116. Swerdlow AJ, Higgins CD, Pike MC. 1997. Risk of testicular cancer in cohort of boys with cryptorchidism. Bmj 314:1507-1511.
117. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA. 1997. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225.
118. Ulbright TM. 1993. Germ cell neoplasms of the testis. Am J Surg Pathol 17:1075-1091.
119. van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH. 1994. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075.
120. Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT, Califano D, Monaco C, Mineo A, Santelli G, Manzo G, Botti G, Chiappetta G, Persieo MG. 1996. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 13:577-587.
121. von Eyben FE, Jacobsen GK, Rorth M, Von Der Maase H. 2004. Microinvasive germ cell tumor (MGCT) adjacent to testicular germ cell tumors. Histopathology 44:547-554.
122. Watanabe S, Umehara H, Murayama K, Okabe M, Kimura T, Nakano T 2006. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25:2697-2707.
123. Waterhouse JA. 1985. Epidemiology of testicular tumors. J R Soc Med 78 Suppl 6:3-7.
124. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. 2000. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 87:438-443.
125. Wennerberg K, Rossman KL, Der CJ. 2005. The Ras superfamily at a glance. J Cell Sci 118:843-846.
126. Willmore-Payne C, Holden JA, Tripp S, Layfield LJ. 2005. Human malignant melanoma: Detection of BRAF- and c-kit-activating mutations bv high-resolution amplicon melting analysis. Hum Pathol 36:486-493.
127. Ye DW, Zheng J, Qian SX, Ma Y, Zheng X, Li D, Gu S. 1993. p53 gene mutations in Chinese human testicular seminoma. J Urol 150:884-886.
128. Yu Q, Ciemerych MA, Sicinski P. 2005. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins. Oncogene 24:7114-7119.
129. Zhang Y, Graubard BI, Klebanoff MA, Ronckers C, Stanczyk FZ, Longnecker MP, McGlynn KA. 2005. Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer 92:1787-1793.